Is it time for international consensus clinical guideline development for digital papillary adenocarcinoma?
Response to Joshi and Kimyai-Asadi, ‘Epidemiology, survival, and risk of subsequent primary malignancies in patients with digital papillary adenocarcinoma: a retrospective study of 213 patients in the Surveillance, Epidemiology, and End Results (SEER) Program’.
Authors
- Paul Craig (ORCID: https://orcid.org/0000-0003-0886-0403)
- Kashini Andrew (ORCID: https://orcid.org/0000-0001-5054-1225)
- Neil Rajan (ORCID: https://orcid.org/0000-0002-5850-5680)
- Simon Tso (ORCID: https://orcid.org/0000-0001-9221-7618)
- Zoe Claire Venables (ORCID: https://orcid.org/0000-0002-9929-2693)
- Simon Unter
- B. C. Gee
Institutions
- University of East Anglia (GB)
- Norfolk and Norwich University Hospitals NHS Foundation Trust (GB)
- Gloucestershire Hospitals NHS Foundation Trust (GB)
- NHS Digital (GB)
- South Warwickshire NHS Foundation Trust (GB)
- NHS England
- Cardiff University (GB)
- Newcastle University (GB)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1093/ced/llae428
- Citations
- 1
- Primary Topic
- Breast Lesions and Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.42